Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News HFSA 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Todd Neale

October 01, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

Todd Neale

August 03, 2020

News Daily News

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Yael L. Maxwell

May 29, 2020

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

Advertisement

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Amylin Analogue Boosts Weight Loss When Added to GLP-1

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Top General Cardiology and Prevention News of 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Semaglutide Has Similar Benefits in Women and Men With HFpEF

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content